Quick Answer
Connect Biopharma Holdings Ltd reported Total Revenue of $64.0 thousand for the year ending 2025.
- Connect Biopharma Holdings Ltd showed a decrease of -99.8% in Total Revenue from 2024 to 2025.
- This data is from Connect Biopharma Holdings Ltd's annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2023 to 2025 (3 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2024: $24.12 million | Q3 2024: $1.22 million | Q2 2025: $48.0 thousand | Q3 2025: $16.0 thousand.
- Historical annual values: Fiscal year 2025: $64.0 thousand | Fiscal year 2024: $26.03 million | Fiscal year 2023: $0.00.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: